Healthcare provider profile · identity verified

Sean Lynd, MD

Internal Medicine · CINCINNATI, OH · NPI 1518901511

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1294	337
Amlodipine Besylate	Amlodipine Besylate	466	116
Omeprazole	Omeprazole	365	108
Losartan Potassium	Losartan Potassium	310	79
Metoprolol Succinate	Metoprolol Succinate	301	73
Alendronate Sodium	Alendronate Sodium	287	79
Sertraline Hcl	Sertraline Hcl	285	74
Benazepril Hcl	Benazepril Hcl	257	65
Lisinopril	Lisinopril	250	73
Levothyroxine Sodium	Levothyroxine Sodium	243	59
Rosuvastatin Calcium	Rosuvastatin Calcium	213	62
Hydrochlorothiazide	Hydrochlorothiazide	210	58
Pantoprazole Sodium	Pantoprazole Sodium	202	48
Meloxicam	Meloxicam	191	60
Metformin Hcl Er	Metformin Hcl	180	49
Furosemide	Furosemide	167	46
Tamsulosin Hcl	Tamsulosin Hcl	164	52
Duloxetine Hcl	Duloxetine Hcl	156	40
Simvastatin	Simvastatin	156	43
Allopurinol	Allopurinol	134	34
Atenolol	Atenolol	122	26
Eliquis	Apixaban	119	33
Glimepiride	Glimepiride	117	30
Pravastatin Sodium	Pravastatin Sodium	97	26
Trazodone Hcl	Trazodone Hcl	96	29
Fluticasone Propionate	Fluticasone Propionate	95	35
Venlafaxine Hcl Er	Venlafaxine Hcl	93	20
Potassium Chloride	Potassium Chloride	90	22
Ezetimibe	Ezetimibe	88	25
Metformin Hcl	Metformin Hcl	88	25
Albuterol Sulfate Hfa	Albuterol Sulfate	84	46
Trulicity	Dulaglutide	79	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	78	20
Donepezil Hcl	Donepezil Hcl	77	19
Jardiance	Empagliflozin	75	16
Spironolactone	Spironolactone	66	18
Warfarin Sodium	Warfarin Sodium	66	12
Farxiga	Dapagliflozin Propanediol	65	15
Gabapentin	Gabapentin	65	15
Ozempic	Semaglutide	64	14
Bupropion Xl	Bupropion Hcl	63	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	62	17
Carvedilol	Carvedilol	60	20
Esomeprazole Magnesium	Esomeprazole Magnesium	59	11
Nifedipine Er	Nifedipine	59	15
Buspirone Hcl	Buspirone Hcl	56	suppressed
Celecoxib	Celecoxib	56	17
Diclofenac Sodium	Diclofenac Sodium	54	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	13
Triamcinolone Acetonide	Triamcinolone Acetonide	54	33
Terazosin Hcl	Terazosin Hcl	53	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	14
Pioglitazone Hcl	Pioglitazone Hcl	52	15
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	51	11
Januvia	Sitagliptin Phosphate	51	suppressed
Klor-Con M20	Potassium Chloride	51	17
Famotidine	Famotidine	50	17
Mounjaro	Tirzepatide	50	11
Naproxen	Naproxen	50	24
Fenofibrate	Fenofibrate	49	11
Clopidogrel	Clopidogrel Bisulfate	48	13
Ropinirole Hcl	Ropinirole Hcl	48	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	23
Fluoxetine Hcl	Fluoxetine Hcl	45	12
Colestipol Hcl	Colestipol Hcl	44	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	12
Ramipril	Ramipril	42	11
Finasteride	Finasteride	39	11
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Novolog Flexpen	Insulin Aspart	37	11
Pregabalin	Pregabalin	36	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	35	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	34	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	30
Olanzapine	Olanzapine	30	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	29	29
Synthroid	Levothyroxine Sodium	29	suppressed
Valsartan	Valsartan	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Primidone	Primidone	28	suppressed
Felodipine Er	Felodipine	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	24
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Glipizide	Glipizide	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Prednisone	Prednisone	25	16
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	12
Meclizine Hcl	Meclizine Hcl	21	17
Repatha Sureclick	Evolocumab	21	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	21	suppressed
Tradjenta	Linagliptin	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Irbesartan	Irbesartan	19	suppressed
Lorazepam	Lorazepam	19	11
Lovastatin	Lovastatin	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Jantoven	Warfarin Sodium	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Methylprednisolone	Methylprednisolone	17	17
Tramadol Hcl	Tramadol Hcl	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Colchicine	Colchicine	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	16	suppressed
Ketoconazole	Ketoconazole	16	11
Metolazone	Metolazone	16	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	15	suppressed
Digoxin	Digoxin	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	11
Klor-Con M10	Potassium Chloride	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	11
Folic Acid	Folic Acid	13	suppressed
Risperidone	Risperidone	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Enulose	Lactulose	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Glyxambi	Empagliflozin/Linagliptin	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error